Tailored radiation boosts survival in lung cancer trial
NCT ID NCT07164885
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to deliver radiation therapy for people with stage III lung cancer that cannot be removed by surgery. The treatment is personalized based on each patient's tumor sensitivity to radiation. The goal is to see if this approach helps people live longer and keeps the cancer from growing, compared to standard radiation. About 900 adults with this type of lung cancer will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Hong Kong Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, 518000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a PET scan reveal hidden heart harm from lung cancer treatment?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Can a new drug shrink Hard-to-Treat tumors?
- Could an asthma drug help fight lung cancer? early trial investigates
- New combo therapy aims to boost lung cancer survival
- Radiation 'Priming' could make lung cancer treatment more effective